Phase I study of lapatinib and pemetrexed in the second-line treatment of advanced or metastatic non-small-cell lung cancer with assessment of circulating cell free thymidylate synthase RNA as a potential biomarker

Saved in:
Bibliographic Details
Main Authors: Ramlau, Rodryg (Author) , Thomas, Michael (Author)
Format: Article (Journal)
Language:English
Published: September 2015
In: Clinical lung cancer
Year: 2015, Volume: 16, Issue: 5, Pages: 348-357
ISSN:1938-0690
DOI:10.1016/j.cllc.2015.01.004
Online Access:Verlag, Volltext: http://dx.doi.org/10.1016/j.cllc.2015.01.004
Get full text
Author Notes:Rodryg Ramlau, Michael Thomas, Silvia Novello, Ruth Plummer, Martin Reck, Tomomi Kaneko, Mike R. Lau, Jane Margetts, John Lunec, Joyce Nutt, Giorgio V. Scagliotti
Description
Item Description:Gesehen am 04.01.2017
Physical Description:Online Resource
ISSN:1938-0690
DOI:10.1016/j.cllc.2015.01.004